title: Mechanisms of illness progression in the recurrent affective disorders.
abstract: Along with genetic vulnerability, multiple environmental factors convey liability to illness progression, including: (1) distal and proximal stressors; (2) recurrence of episodes; and (3) comorbid cocaine abuse. Recurrence of each of these can increase responsivity (sensitize) to themselves and cross-sensitize to the two other factors and drive illness progression as seen clinically in increases in cycle acceleration, severity or duration of episodes, treatment refractoriness, disability, cognitive dysfunction, and premature death. Some mechanisms appear common to all three types of sensitization, such as decreases of brain-derived neuroprotective factor (BDNF) in hippocampus and blood, as well as increases in BDNF in the nucleus accumbens, suggesting the possibility that single treatments could ameliorate several of these factors at once. A potential example is N-acetylcysteine (NAC), which decreases bipolar affective illness severity (Berk et al. Biol Psychiatry 64:468–475, 2008) and cocaine reinstatement and craving (Baker et al. Ann N Y Acad Sci 1003:349–351, 2003; LaRowe et al. Am J Addict 15:105–110, 2006). Mechanisms of illness progression also involve epigenetic changes and add further rationale to the existing empirical clinical evidence of the importance of early recognition, treatment, and prevention of affective episodes. Adequate treatment could prevent or ameliorate both the increases in pathological factors and erosion of adaptive factors that propel illness exacerbation and treatment resistance. This view of the sensitization and cross-sensitization among stressors, episodes, and abused substances should lead to a fundamental re-conceptualization of the recurrent affective disorders not as benign, isolated episodes of “mental” illness, but as severe, potentially progressive and lethal medical disorders of brain and body that deserve careful life-long monitoring and treatment.
authors.affiliation: Bipolar Collaborative Network, 5415 W. Cedar Lane, Suite 201-B, Bethesda, MD 20814, USA. robert.post@speakeasy.net
authors.forename: Robert M
authors.initials: RM
authors.lastname: Post
mesh_terms: D000818:Animals; D019970:Cocaine-Related Disorders / Q000150:complications / Q000523:psychology; D018450:Disease Progression; D006801:Humans; D019964:Mood Disorders / Q000209:etiology* / Q000517:prevention & control / Q000523:psychology*; D055502:Secondary Prevention; D012931:Social Environment; D013315:Stress, Psychological / Q000150:complications / Q000523:psychology
references.citation: Am J Addict. 2006 Jan-Feb;15(1):105-10
references.pmid: 16449100
references.citation: Biol Psychiatry. 1998 Aug 1;44(3):193-206
references.pmid: 9693391
references.citation: Biol Psychiatry. 2009 May 1;65(9):760-9
references.pmid: 19150054
references.citation: Bipolar Disord. 2009 Nov;11(7):744-52
references.pmid: 19719787
references.citation: Biol Psychiatry. 2004 May 1;55(9):875-81
references.pmid: 15110730
references.citation: Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
references.pmid: 4110397
references.citation: Biol Psychiatry. 2000 Jul 1;48(1):1-8
references.pmid: 10913502
references.citation: Br J Psychiatry. 1998 Jan;172:23-8
references.pmid: 9534827
references.citation: JAMA. 2007 Oct 17;298(15):1794-6
references.pmid: 17940236
references.citation: Psychiatry Res. 2008 Oct 30;164(1):30-47
references.pmid: 18801648
references.citation: Biol Psychiatry. 2008 Sep 15;64(6):468-75
references.pmid: 18534556
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1151-9
references.pmid: 16566899
references.citation: Science. 2006 Feb 10;311(5762):864-8
references.pmid: 16469931
references.citation: Am J Psychiatry. 2003 Aug;160(8):1516-8
references.pmid: 12900317
references.citation: Am J Psychiatry. 2001 Apr;158(4):582-6
references.pmid: 11282692
references.citation: J Affect Disord. 2007 Dec;104(1-3):91-5
references.pmid: 17434599
references.citation: J Nerv Ment Dis. 1994 Jun;182(6):349-52
references.pmid: 8201307
references.citation: Nat Neurosci. 2007 Sep;10(9):1089-93
references.pmid: 17726474
references.citation: Mol Neurobiol. 1996 Aug;13(1):33-60
references.pmid: 8892335
references.citation: Expert Rev Neurother. 2008 Jul;8(7):1101-13
references.pmid: 18590480
references.citation: J Psychiatry Neurosci. 2009 Jul;34(4):263-71
references.pmid: 19568477
references.citation: J Psychiatr Res. 2007 Dec;41(12):979-90
references.pmid: 17239400
references.citation: Ann Clin Psychiatry. 2003 Jun;15(2):85-94
references.pmid: 12938866
references.citation: Neurosci Biobehav Rev. 2008;32(4):675-92
references.pmid: 18199480
references.citation: J Affect Disord. 2008 Dec;111(2-3):135-44
references.pmid: 18539338
references.citation: Biol Psychiatry. 2007 Oct 15;62(8):894-900
references.pmid: 17617385
references.citation: J Clin Psychiatry. 2010 Jul;71(7):864-72
references.pmid: 20667291
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19186-91
references.pmid: 16380431
references.citation: J Clin Psychiatry. 2006 Jan;67(1):115-25
references.pmid: 16426098
references.citation: J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1662-6
references.pmid: 15548477
references.citation: Learn Mem. 2007 Apr 06;14(4):268-76
references.pmid: 17522015
references.citation: Neuron. 2005 Oct 20;48(2):303-14
references.pmid: 16242410
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1116-27
references.pmid: 16631126
references.citation: Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44
references.pmid: 1665095
references.citation: Br J Psychiatry. 2008 Apr;192(4):290-3
references.pmid: 18378992
references.citation: Brain Res Mol Brain Res. 1991 Aug;11(1):55-64
references.pmid: 1662746
references.citation: Biol Psychiatry. 2004 Apr 1;55(7):708-14
references.pmid: 15038999
references.citation: Bipolar Disord. 2006 Apr;8(2):103-16
references.pmid: 16542180
references.citation: Eur Arch Psychiatry Clin Neurosci. 1999;249(5):227-30
references.pmid: 10591987
references.citation: Exp Neurol. 1969 Nov;25(3):295-330
references.pmid: 4981856
references.citation: Nat Neurosci. 2005 Nov;8(11):1445-9
references.pmid: 16251986
references.citation: Biol Psychiatry. 1992 Sep 15;32(6):469-84
references.pmid: 1445965
references.citation: Exp Neurol. 2005 Apr;192(2):235-43
references.pmid: 15755541
references.citation: J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1380-6
references.pmid: 15502597
references.citation: Nat Rev Neurosci. 2007 May;8(5):355-67
references.pmid: 17453016
references.citation: J Psychiatr Res. 2009 Jan;43(3):274-81
references.pmid: 18656896
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3480-5
references.pmid: 16484373
references.citation: Curr Psychiatry Rep. 2005 Dec;7(6):413-20
references.pmid: 16318818
references.citation: Ann N Y Acad Sci. 2003 Nov;1003:349-51
references.pmid: 14684458
references.citation: Biol Psychiatry. 2003 Nov 15;54(10):1025-34
references.pmid: 14625144
references.citation: Acta Psychiatr Scand Suppl. 2007;(434):17-26
references.pmid: 17688459
references.citation: Sci Am. 1987 Jun;256(6):80-9
references.pmid: 3589645
references.citation: Neuropsychopharmacology. 2008 Jan;33(1):166-80
references.pmid: 17805308
references.citation: Int J Neuropsychopharmacol. 2009 May;12(4):447-58
references.pmid: 18771602
references.citation: Brain Res Brain Res Rev. 1995 Mar;20(3):305-25
references.pmid: 7550363
references.citation: Bipolar Disord. 2007 Jun;9 Suppl 1:128-35
references.pmid: 17543031
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1227-35
references.pmid: 16457784
references.citation: Prev Chronic Dis. 2006 Apr;3(2):A42
references.pmid: 16539783
references.citation: Brain Res Mol Brain Res. 1992 Oct;15(3-4):247-55
references.pmid: 1359374
references.citation: Pharmacol Biochem Behav. 1983 Jan;18(1):61-3
references.pmid: 6828538
references.citation: Am J Psychiatry. 1992 Aug;149(8):999-1010
references.pmid: 1353322
references.citation: Neurosci Biobehav Rev. 2007;31(6):858-73
references.pmid: 17555817
references.citation: Life Sci. 1975 Sep 15;17(6):943-50
references.pmid: 1238889
references.citation: J Affect Disord. 2006 Jul;93(1-3):105-15
references.pmid: 16677713
references.citation: Nat Neurosci. 2006 Apr;9(4):519-25
references.pmid: 16501568
references.citation: Neurotox Res. 2008 Oct;14(2-3):185-9
references.pmid: 19073425
references.citation: Am J Psychiatry. 2001 Mar;158(3):420-6
references.pmid: 11229983
references.citation: Biol Psychiatry. 2007 Jul 1;62(1):7-16
references.pmid: 17240360
references.citation: Arch Gen Psychiatry. 2008 Nov;65(11):1331-5
references.pmid: 18981345
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6406-11
references.pmid: 17379666
references.citation: Am J Psychiatry. 2000 Aug;157(8):1243-51
references.pmid: 10910786
references.citation: J Pediatr. 2007 May;150(5):485-90
references.pmid: 17452221
references.citation: J Affect Disord. 2006 Oct;95(1-3):43-9
references.pmid: 16837055
references.citation: Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76
references.pmid: 18205981
references.citation: Am J Psychiatry. 2005 Aug;162(8):1403-13
references.pmid: 16055761
references.citation: Biol Psychiatry. 2008 Feb 1;63(3):338-40
references.pmid: 17719565
references.citation: Biol Psychiatry. 2008 Aug 15;64(4):336-43
references.pmid: 18468583